Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 known ✓ | P22748 | 5/20 | 0.56 |
| ▸ | CA1 known ✓ | P00915 | 4/20 | 0.42 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.42 |
| ▸ | CA12 known ✓ | O43570 | 1/20 | 0.42 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.38 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30998842 | 1.00 | CA4 (0.56) | CA4FFAR3HDAC3HDAC1HDAC2 | |
| SCHEMBL30917295 | 0.97 | CA4 (0.53) | CA4FFAR3HDAC3HDAC1HDAC2 | |
| Water SCHEMBL10705905 | 0.97 | CA4 (0.53) | CA4FFAR3HDAC3HDAC1HDAC2 | |
| SCHEMBL29707468 | 0.94 | CA4 (0.50) | CA4FFAR3HDAC3HDAC1HDAC2 | |
| SCHEMBL112322 | 0.94 | — | — | |
| SCHEMBL1882178 | 0.93 | CA4 (0.50) | CA4FFAR3HDAC3HDAC1HDAC2 | |
| SCHEMBL2947828 | 0.93 | CA4 (0.50) | CA4FFAR3HDAC3HDAC1HDAC2 | |
| SCHEMBL5183804 | 0.93 | CA4 (0.50) | CA4FFAR3HDAC3HDAC1HDAC2 | |
| SCHEMBL329100 | 0.93 | CA4 (0.50) | CA4FFAR3HDAC3HDAC1HDAC2 | |
| Lithium Ion SCHEMBL3464173 | 0.93 | CA4 (0.50) | CA4FFAR3HDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 555 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080673-A | Rare earth nano coating with high bonding energy and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-119263329-B | Preparation method of barium hydroxide octahydrate | 山东辰安化学有限公司 | 2025-05-09 | — | — | CN | claimed |
| US-20250091013-A1 | Three-Compartment Bipolar Membrane Electrodialysis Of Salts Of Amino Acids | MONSANTO TECHNOLOGY LLC | 2025-03-20 | — | — | US | claimed |
| CN-119499861-A | Synergistic accelerator suitable for SNCR denitration and application thereof | 华东理工大学 | 2025-02-25 | — | — | CN | claimed |
| CN-119481578-A | Sodium ion battery diaphragm coating slurry, coated diaphragm and sodium ion battery | 湖南裕能新能源电池材料股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119409264-A | Method for removing antimony by using zirconium functionalized adsorption resin | 杨凌核盛辐照技术有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-119340608-A | Separator, battery and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-119263329-A | Preparation method of barium hydroxide octahydrate | 山东辰安化学有限公司 | 2025-01-07 | — | — | CN | claimed |
| US-12186709-B2 | Three-compartment bipolar membrane electrodialysis of salts of amino acids | MONSANTO TECHNOLOGY LLC (US) | 2025-01-07 | — | — | US | claimed |
| CN-119020787-A | Etching solution and application of etching solution in etching more than two layers of metal films | 上海盛剑微电子有限公司 | 2024-11-26 | — | — | CN | claimed |
| WO-2001077054-A2 | PROCESS AND CATALYST FOR DEHYDROGENATING PRIMARY ALCOHOLS TO MAKE CARBOXYLIC ACID SALTS | MONSANTO TECHNOLOGY LLC (US) | 2001-10-18 | — | — | WO | claimed |
| JP-2001508043-A | — | — | 2001-06-19 | — | — | JP | claimed |
| WO-2000066539-A1 | PROCESS FOR THE PREPARATION OF CARBOXYLIC ACID SALTS FROM PRIMARY ALCOHOLS | MONSANTO TECHNOLOGY LLC (US) | 2000-11-09 | — | — | WO | claimed |
| US-5986128-A | ACIDIFICATION AND PHOSPHONATION | MONSANTO COMPANY (US) | 1999-11-16 | — | — | US | claimed |
| EP-0935595-A1 | USE OF MONOSODIUM IMINODIACETIC ACID SOLUTIONS IN THE PREPARATION OF N-PHOSPHONOMETHYLIMINODIACETIC ACID | MONSANTO COMPANY (US) | 1999-08-18 | — | — | EP | claimed |
| WO-1998019992-A1 | USE OF MONOSODIUM IMINODIACETIC ACID SOLUTIONS IN THE PREPARATION OF N-PHOSPHONOMETHYLIMINODIACETIC ACID | MONSANTO COMPANY (US) | 1998-05-14 | — | — | WO | claimed |
| EP-0165728-B1 | NMR CONTRAST AGENTS | NYCOMED AS (NO) | 1988-12-14 | — | — | EP | claimed |
| EP-0180673-B1 | MIXTURES CONTAINING NITRILOTRIACETIC ACID AND IMINODIACETIC ACID (OR SALTS THEREOF) AS A SEQUESTERING AGENT | THE DOW CHEMICAL COMPANY (US) | 1988-09-14 | — | — | EP | claimed |
| EP-0180673-A1 | Mixtures containing nitrilotriacetic acid and iminodiacetic acid (or salts thereof) as a sequestering agent | THE DOW CHEMICAL COMPANY (US) | 1986-05-14 | — | — | EP | claimed |
| US-4486339-A | CHELATION OF CALCIUM AND MAGNESIUM, DETERGENT FORMULATIONS | THE DOW CHEMICAL COMPANY (US) | 1984-12-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12186709-B2 | Three-compartment bipolar membrane electrodialysis of salts of amino acids | SLC1A3, SLC1A2, SLC1A1 | CA4 1562/4885CA1 453/4885CA2 167/4885 |
| US-20250091013-A1 | Three-Compartment Bipolar Membrane Electrodialysis Of Salts Of Amino Acids | SLC1A3, SLC1A2, SLC1A1 | CA4 1562/4885CA1 453/4885CA2 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.